113 related articles for article (PubMed ID: 8968342)
21. Sexual dimorphism of erythropoietin-degrading activity in mouse submaxillary gland extracts.
Tam RC; Bedwell J; Cotes PM; Reed PJ
Exp Hematol; 1989 Feb; 17(2):160-3. PubMed ID: 2912738
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic analysis of continuous erythropoietin receptor activator disposition in adult sheep using a target-mediated, physiologic recirculation model and a tracer interaction methodology.
El-Komy MH; Widness JA; Veng-Pedersen P
Drug Metab Dispos; 2011 Apr; 39(4):603-9. PubMed ID: 21209249
[TBL] [Abstract][Full Text] [Related]
23. Receptor-based model accounts for phlebotomy-induced changes in erythropoietin pharmacokinetics.
Chapel SH; Veng-Pedersen P; Schmidt RL; Widness JA
Exp Hematol; 2001 Apr; 29(4):425-31. PubMed ID: 11301182
[TBL] [Abstract][Full Text] [Related]
24. Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin.
Jolling K; Perez Ruixo JJ; Hemeryck A; Vermeulen A; Greway T
Eur J Pharm Sci; 2005 Apr; 24(5):465-75. PubMed ID: 15784336
[TBL] [Abstract][Full Text] [Related]
25. Damage of tracer erythropoietin results in erroneous estimation of concentration in mouse submaxillary gland.
Vidal A; Carcagno M; Criscuolo M; Barcelò AC; Alippi RM; Leal T; Bozzini CE
Exp Hematol; 1993 Feb; 21(2):299-302. PubMed ID: 8425566
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin treatment improves liver regeneration and survival in rat models of extended liver resection and living donor liver transplantation.
Bockhorn M; Fingas CD; Rauen U; Canbay A; Sotiropoulos GC; Frey U; Sheu SY; Wohlschläger J; Broelsch CE; Schlaak JF
Transplantation; 2008 Dec; 86(11):1578-85. PubMed ID: 19077893
[TBL] [Abstract][Full Text] [Related]
27. Clinical pharmacokinetics of lyophilized recombinant human erythropoietin-alpha following single-dose subcutaneous administration in premature newborns.
Melo AM; Costa MT; Porta V; Vaz FA
J Matern Fetal Neonatal Med; 2005 Jan; 17(1):55-8. PubMed ID: 15804788
[TBL] [Abstract][Full Text] [Related]
28. Liver to kidney switch of erythropoietin formation.
Zanjani ED
Exp Hematol; 1980; 8 Suppl 8():29-40. PubMed ID: 7349641
[TBL] [Abstract][Full Text] [Related]
29. A differential pharmacokinetic analysis of the erythropoietin receptor population in newborn and adult sheep.
Veng-Pedersen P; Chapel S; Al-Huniti NH; Schmidt RL; Sedars EM; Hohl RJ; Widness JA
J Pharmacol Exp Ther; 2003 Aug; 306(2):532-7. PubMed ID: 12750427
[TBL] [Abstract][Full Text] [Related]
30. The effect of centrally administered erythropoietin on cardiovascular and respiratory system of anaesthetized rats.
Yalcin M; Ak F; Cangul IT; Erturk M
Auton Neurosci; 2007 Jul; 134(1-2):1-7. PubMed ID: 17306629
[TBL] [Abstract][Full Text] [Related]
31. The role of erythropoietin in hemorrhagic shock-induced liver and renal injury in rats.
Algin MC; Hacioglu A; Yaylak F; Gulcan E; Aydin T; Hacioglu BA; Ilhan D; Cevik AA; Ates E
Adv Ther; 2008 Dec; 25(12):1353-74. PubMed ID: 19002406
[TBL] [Abstract][Full Text] [Related]
32. Developmental stage-specific expression of the alpha and beta subunits of the HIF-1 protein in the mouse and human fetus.
Madan A; Varma S; Cohen HJ
Mol Genet Metab; 2002 Mar; 75(3):244-9. PubMed ID: 11914036
[TBL] [Abstract][Full Text] [Related]
33. The in vivo metabolism of recombinant human erythropoietin in the rat.
Spivak JL; Hogans BB
Blood; 1989 Jan; 73(1):90-9. PubMed ID: 2462945
[TBL] [Abstract][Full Text] [Related]
34. Expression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignancies.
Kokhaei P; Abdalla AO; Hansson L; Mikaelsson E; Kubbies M; Haselbeck A; Jernberg-Wiklund H; Mellstedt H; Osterborg A
Clin Cancer Res; 2007 Jun; 13(12):3536-44. PubMed ID: 17575216
[TBL] [Abstract][Full Text] [Related]
35. Erythropoietin promotes hepatic regeneration after extended liver resection in rats.
Schmeding M; Boas-Knoop S; Lippert S; Ruehl M; Somasundaram R; Dagdelen T; Neuhaus P; Neumann UP
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1125-31. PubMed ID: 18086112
[TBL] [Abstract][Full Text] [Related]
36. The effect of hepatectomy and nephrectomy on the anaesthetic activity of some N-substituted barbiturates.
SANDBERG F
Acta Physiol Scand; 1953 Mar; 28(1):1-5. PubMed ID: 13065145
[No Abstract] [Full Text] [Related]
37. Erythropoietin reduces ischemia-reperfusion injury in the rat liver.
Schmeding M; Neumann UP; Boas-Knoop S; Spinelli A; Neuhaus P
Eur Surg Res; 2007; 39(3):189-97. PubMed ID: 17377393
[TBL] [Abstract][Full Text] [Related]
38. Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure.
Eliopoulos N; Gagnon RF; Francois M; Galipeau J
J Am Soc Nephrol; 2006 Jun; 17(6):1576-84. PubMed ID: 16672321
[TBL] [Abstract][Full Text] [Related]
39. The prolonged half-lives of new erythropoietin derivatives via peptide addition.
Lee DE; Son W; Ha BJ; Oh MS; Yoo OJ
Biochem Biophys Res Commun; 2006 Jan; 339(1):380-5. PubMed ID: 16314154
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin production rate in phlebotomy-induced acute anemia.
Al-Huniti NH; Widness JA; Schmidt RL; Veng-Pedersen P
Biopharm Drug Dispos; 2004 Dec; 25(9):389-97. PubMed ID: 15529399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
